Injections of human or murine SAP inhibit inflammation and fibrosis in animal models of pulmonary fibrosis [24], [30], [32], cardiac fibrosis [25], [29], dermal wound healing [23], radiation-induced oral mucositis [31], allergic airway disease [34], experimental autoimmune encephalomyelitis [36], and kidney injury [33]. The gene discussed is APCS; the disease is pulmonary fibrosis.